SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-24-002600
Filing Date
2024-02-14
Accepted
2024-02-14 09:00:10
Documents
1
Group Members
AMOS MERON

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 aeon130245sc13ga1.htm SC 13G/A 49803
  Complete submission text file 0001214659-24-002600.txt   51553
Mailing Address 10250 CONSTELLATION BOULEVARD SUITE 2950 LOS ANGELES CA 90067
Business Address 10250 CONSTELLATION BOULEVARD SUITE 2950 LOS ANGELES CA 90067 (310)843-9900
Empyrean Capital Partners, LP (Filed by) CIK: 0001317195 (see all company filings)

IRS No.: 522403815 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Subject) CIK: 0001837607 (see all company filings)

IRS No.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92271 | Film No.: 24632786
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)